Skip to main content
. 2021 Jan 27;21(3):831. doi: 10.3390/s21030831

Figure 5.

Figure 5

Fluorescence intensity spectra of Eu3+ chelated by PMDA modified anti-human myoglobin Affimer complex in 1% (v/v) human serum. Fluorescence was measured at 590 and 615 nm with λex = 395 nm. (a) Fluorescence intensity spectra of Eu3+ chelated PMDA modified anti-human myoglobin Affimer; (b), fluorescence intensity spectra of the same complex after HFABP3 (control) added; (c) percentage change in fluorescence intensity; (d) photoluminescence intensity ratio. Data are means ± SEM (n = 4). Some error bars are smaller than data points (*, ** and *** indicate significance with p-value < 0.05, 0.01, and 0.001 respectively of the specific analyte (human myoglobin) compared to the control (HFAPB3) data).